Form 8-K - Current report:
SEC Accession No. 0001628280-25-035754
Filing Date
2025-07-23
Accepted
2025-07-23 16:33:17
Documents
22
Period of Report
2025-05-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K jan-20250509.htm   iXBRL 8-K 43689
2 EX-23.1 ex231_franklapostacpa.htm EX-23.1 2318
3 EX-99.1 ex991_mswipe2025audit.htm EX-99.1 176058
4 EX-99.2 ex-99_2xmswipex070725.htm EX-99.2 21235
5 EX-99.3 a993_alt5q1resultsmswipexd.htm EX-99.3 20211
9 image_01.jpg GRAPHIC 374031
10 image_0a.jpg GRAPHIC 9442
11 image_0b.jpg GRAPHIC 107000
12 image_1a.jpg GRAPHIC 609228
13 image_2a.jpg GRAPHIC 37329
14 image_3a.jpg GRAPHIC 12096
  Complete submission text file 0001628280-25-035754.txt   1989766

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jan-20250509.xsd EX-101.SCH 1810
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jan-20250509_lab.xml EX-101.LAB 22804
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jan-20250509_pre.xml EX-101.PRE 13069
25 EXTRACTED XBRL INSTANCE DOCUMENT jan-20250509_htm.xml XML 2824
Mailing Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119
Business Address 325 E. WARM SPRINGS ROAD SUITE 102 LAS VEGAS NV 89119 702-997-5968
ALT5 Sigma Corp (Filer) CIK: 0000862861 (see all company filings)

EIN.: 411454591 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19621 | Film No.: 251143483
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)